GEHC GE HealthCare Technologies Inc.

$75.51

*Only the 1D chart reflects 15-min delayed quotes during market hours. Other timeframes update after market close.

Reporting for fiscal period ending —
Expected on —
Report Time: Unknown Release Time
The Whisper Number
—
Consensus Estimate: —
Revenue Estimate: —

Latest Earnings Insight

Updated On 10/2/2025

About GE HealthCare Technologies Inc.

GE HealthCare Technologies Inc. provides medical technology, pharmaceutical diagnostics, and digital solutions in the United States. The company is headquartered in Chicago, Illinois.

Website: https://www.gehealthcare.com

Sector
LIFE SCIENCES
Industry
X-RAY APPARATUS & TUBES & RELATED IRRADIATION APPARATUS
Exchange
NASDAQ
Country
USA
Currency
USD
Fiscal Year End
December
CIK
1932393
Address
500 W. MONROE STREET, CHICAGO, IL, UNITED STATES
Valuation
Market Cap
$28.56B
P/E Ratio
14.37
PEG Ratio
1.64
Price to Book
3.38
Performance
EPS
$4.34
Dividend Yield
0.22%
Profit Margin
10.10%
ROE
25.70%
Technicals
50D MA
$80.71
200D MA
$83.72
52W High
$94.80
52W Low
$57.65
Fundamentals
Shares Outstanding
458M
Target Price
$98.95
Beta
1.31

GEHC EPS Estimates vs Actual

● Estimated
● Actual

GEHC News & Sentiment

Sep 26, 2025 • Zacks Commentary SOMEWHAT-BULLISH
GEHC Inks License Agreement With Lantheus for Prostate Imaging Agent
GE HealthCare strengthens its radiopharmaceutical portfolio by licensing Lantheus' PSMA PET imaging agent, PYLARIFY, for commercialization in Japan.
Sep 25, 2025 • Benzinga NEUTRAL
Trump Administration Review Targets Medical Supply Chain - Becton Dickinson ( NYSE:BDX ) , Baxter Intl ( NYSE:BAX )
The U.S. Commerce Department, under the Trump administration, has launched a national security review of medical imports-including PPE, consumables, and medical devices-to assess reliance on foreign suppliers for critical health products.
Sep 24, 2025 • Zacks Commentary SOMEWHAT-BULLISH
Is it a Prudent Move to Retain BSX Stock in Your Portfolio for Now?
Boston Scientific's acquisitions and WATCHMAN growth fuel optimism, but currency swings and macro pressures weigh on its outlook.
Sep 23, 2025 • Zacks Commentary SOMEWHAT-BULLISH
Reasons to Add Labcorp Stock to Your Portfolio Right Now
LH's biopharma lab growth and efficiency gains boost momentum, but currency and macro pressures weigh on its outlook.
Sep 22, 2025 • Motley Fool NEUTRAL
Should You Invest $1,000 in GE Stock Right Now?
Investors are excited about GE again... for good reason.
Sep 19, 2025 • Zacks Commentary BULLISH
GEHC or A: Which Is the Better Value Stock Right Now?
GEHC vs. A: Which Stock Is the Better Value Option?
Sentiment Snapshot

Average Sentiment Score:

0.322
50 articles with scored sentiment

Overall Sentiment:

Bullish

GEHC Reported Earnings

Apr 30, 2025
Mar 31, 2025 (Pre market)
0.1 Surprise
  • Reported EPS: $1.01
  • Estimate: $0.91
  • Whisper: —
  • Surprise %: 10.6%
Feb 13, 2025
Dec 31, 2024 (Pre market)
0.19 Surprise
  • Reported EPS: $1.45
  • Estimate: $1.26
  • Whisper: —
  • Surprise %: 14.8%
Oct 30, 2024
Sep 30, 2024 (Pre market)
0.09 Surprise
  • Reported EPS: $1.14
  • Estimate: $1.05
  • Whisper: —
  • Surprise %: 8.6%
Jul 31, 2024
Jun 30, 2024 (Pre market)
0.02 Surprise
  • Reported EPS: $1.00
  • Estimate: $0.98
  • Whisper: —
  • Surprise %: 2.0%
Apr 30, 2024
Mar 31, 2024 (Pre market)
-0.01 Surprise
  • Reported EPS: $0.90
  • Estimate: $0.91
  • Whisper: —
  • Surprise %: -1.1%
Feb 06, 2024
Dec 31, 2023 (Pre market)
0.11 Surprise
  • Reported EPS: $1.18
  • Estimate: $1.07
  • Whisper: —
  • Surprise %: 10.3%
Oct 31, 2023
Sep 30, 2023 (Pre market)
0.09 Surprise
  • Reported EPS: $0.99
  • Estimate: $0.90
  • Whisper: —
  • Surprise %: 10.0%
Jul 25, 2023
Jun 30, 2023 (Pre market)
0.05 Surprise
  • Reported EPS: $0.92
  • Estimate: $0.87
  • Whisper: —
  • Surprise %: 5.8%
Apr 25, 2023
Mar 31, 2023 (Pre market)
0.06 Surprise
  • Reported EPS: $0.85
  • Estimate: $0.79
  • Whisper: —
  • Surprise %: 7.6%

Financials